From FDA Panel Backs Amgen Bone Drug, Says Benefits Outweigh Heart Risks:

Green-Lights

Green-Lights—

Photo by Flickr user formulanone https://flic.kr/p/26s11Ds
via a Creative Commons license
https://creativecommons.org/licenses/by-sa/2.0/

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Whitepaper
Decentralized Clinical Trials: The Call for a New Paradigm
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
PRA Health Sciences

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Xconomy on Demand

We offer a number of ways to subscribe for free!